BackPhoenixBio , Ltd. Overview
PhoenixBio Co., Ltd.

PhoenixBio , Ltd. Return on Equity

PhoenixBio , Ltd. (6190.T) has a ROE of 1.02%, below the Healthcare sector average of 13.1%.

Get informed when a big investor buys or sells

+ Follow

ROE

1.02%

Return on Equity

1.02%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

PhoenixBio , Ltd. (6190.T) FAQ

The latest ROE for 6190.T is 1.02%. That is below the Healthcare sector average of 13.1%. Investors often review this figure alongside PhoenixBio , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, 6190.T currently prints 1.02% for ROE, while the sector average sits near 13.1%. That is roughly 92.2% below the sector mean. Large gaps often invite a closer look at PhoenixBio , Ltd.'s growth, margins, and balance sheet.

Return on Equity shows how effectively PhoenixBio , Ltd. converts resources into returns. At 1.02%, 6190.T may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting 6190.T's ROE (1.02%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack PhoenixBio , Ltd.'s ROE against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.